These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 11570508)
1. Flow cytometric assay for the simultaneous analysis of cell-mediated cytotoxicity and effector cell phenotype. Derby E; Reddy V; Baseler M; Malyguine A Biotechniques; 2001 Sep; 31(3):660, 664-5. PubMed ID: 11570508 [No Abstract] [Full Text] [Related]
2. A novel multiparametric flow cytometry-based cytotoxicity assay simultaneously immunophenotypes effector cells: comparisons to a 4 h 51Cr-release assay. Kim GG; Donnenberg VS; Donnenberg AD; Gooding W; Whiteside TL J Immunol Methods; 2007 Aug; 325(1-2):51-66. PubMed ID: 17617419 [TBL] [Abstract][Full Text] [Related]
3. Lymphokine-activated killer cytotoxicity and lymphocyte subpopulations in patients with acute leukemia. Parrado A; Casares S; Rodríguez-Fernández JM Leuk Res; 1994 Nov; 18(11):815-22. PubMed ID: 7526078 [TBL] [Abstract][Full Text] [Related]
4. Characterization of the cytolytic activity of CD4+ and CD8+ tumor-infiltrating lymphocytes in human renal cell carcinoma. Finke JH; Rayman P; Alexander J; Edinger M; Tubbs RR; Connelly R; Pontes E; Bukowski R Cancer Res; 1990 Apr; 50(8):2363-70. PubMed ID: 2107973 [TBL] [Abstract][Full Text] [Related]
5. Phenotypic and functional consequences of herpesvirus saimiri infection of human CD8+ cytotoxic T lymphocytes. Berend KR; Jung JU; Boyle TJ; DiMaio JM; Mungal SA; Desrosiers RC; Lyerly HK J Virol; 1993 Oct; 67(10):6317-21. PubMed ID: 8396687 [TBL] [Abstract][Full Text] [Related]
6. Phenotypical study of human lymphokine-activated killer (LAK) cells. Barral AM; García CA Neoplasma; 1989; 36(5):583-8. PubMed ID: 2682296 [TBL] [Abstract][Full Text] [Related]
7. Natural killer cytotoxicity and lymphocyte subpopulations in patients with acute leukemia. Parrado A; Casares S; Rodríguez-Fernández JM Leuk Res; 1994 Mar; 18(3):191-7. PubMed ID: 7511191 [TBL] [Abstract][Full Text] [Related]
8. Flow cytometric method for simultaneous detection of lymphocyte-K562 conjugates and immunophenotyping of the conjugate forming cells. Radosević K; de Grooth BG; Greve J Cytometry; 1993; 14(5):535-40. PubMed ID: 7689050 [TBL] [Abstract][Full Text] [Related]
9. Recognition and destruction of Bacillus Calmette-Guerin-infected human monocytes. Molloy A; Meyn PA; Smith KD; Kaplan G J Exp Med; 1993 Jun; 177(6):1691-8. PubMed ID: 7684432 [TBL] [Abstract][Full Text] [Related]
11. Adhesion molecules on MHC-nonrestricted lymphocytes: high density expression and role in oncolysis. Savary CA; Lotzová E Lymphokine Cytokine Res; 1992 Jun; 11(3):149-56. PubMed ID: 1391234 [TBL] [Abstract][Full Text] [Related]
12. [Antitumor effector cells in recombinant IL-2 activated tumor infiltrating lymphocytes from human solid cancers]. Ishii S; Shiiba K; Ebina N; Matsuno S Nihon Geka Gakkai Zasshi; 1993 Mar; 94(3):213-24. PubMed ID: 7686244 [TBL] [Abstract][Full Text] [Related]
13. Major histocompatibility complex-unrestricted cytolytic activity of human T cells. Analysis of precursor frequency and effector phenotype. Patel SS; Thiele DL; Lipsky PE J Immunol; 1987 Dec; 139(11):3886-95. PubMed ID: 3500232 [TBL] [Abstract][Full Text] [Related]
14. Discrimination of different subsets of cytolytic cells in pseudorabies virus-immune and naive pigs. de Bruin TG; van Rooij EM; de Visser YE; Voermans JJ; Samsom JN; Kimman TG; Bianchi AT J Gen Virol; 2000 Jun; 81(Pt 6):1529-37. PubMed ID: 10811936 [TBL] [Abstract][Full Text] [Related]
15. Induction of lymphokine-activated killer activity by interleukin 4 in human lymphocytes preactivated by interleukin 2 in vivo or in vitro. Higuchi CM; Thompson JA; Lindgren CG; Gillis S; Widmer MB; Kern DE; Fefer A Cancer Res; 1989 Dec; 49(23):6487-92. PubMed ID: 2479463 [TBL] [Abstract][Full Text] [Related]
16. A comparative study of IL-12 (cytotoxic lymphocyte maturation factor)-, IL-2-, and IL-7-induced effects on immunomagnetically purified CD56+ NK cells. Naume B; Gately M; Espevik T J Immunol; 1992 Apr; 148(8):2429-36. PubMed ID: 1373169 [TBL] [Abstract][Full Text] [Related]
17. The role of lymphotoxin in the IL-2-driven differentiation of human lymphokine-activated T-killer (T-LAK) cells in vitro. Abe Y; Van Eden M; Gatanaga M; Wang FI; Brightbill HD; Granger GA; Gatanaga T Lymphokine Cytokine Res; 1993 Oct; 12(5):279-83. PubMed ID: 8260536 [TBL] [Abstract][Full Text] [Related]
18. [Characterization of lymphokine-activated killer cells obtained from the natural killers--T cells of patients with hepatic tumor lesion]. Vershinina MIu; Khalturina EO; Patiutko IuI; Zabezhinskiĭ DA; Titov KS; Lebedinskaia OV; Vorob'ev AA; Kiselevskiĭ MV; Kuzovlev EN Vestn Ross Akad Med Nauk; 2004; (12):32-6. PubMed ID: 15678686 [TBL] [Abstract][Full Text] [Related]
19. Phenotypic and cell cycle analysis of human peripheral blood mononuclear cells activated with interleukin-2 and/or OKT3. Platts KE; Lawry J; Hancock BW; Rees RC Exp Cell Res; 1993 Sep; 208(1):154-60. PubMed ID: 8359215 [TBL] [Abstract][Full Text] [Related]
20. In vitro responsiveness to interleukins and theophylline of CD16+, CD56- natural killer cells in a patient with chronic granular lymphocyte disorder. Bayle C; Vitté-Mony I; Lang P; Pico J; Hercend T; Bertoglio J Leukemia; 1992 May; 6(5):470-6. PubMed ID: 1375700 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]